Three hundred Black and Latinx teens in Chicago will be recruited to participate in the first clinical trial to measure the potential health benefits of
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain
Colossal, the de-extinction company, announces that the mRNA vaccine it helped to provide research support and acceleration funding for has been administered to the first elephant in
The development of a new artificial intelligence-based tool that supports health professionals caring for people with diabetes has led to national recognition for a Northumbria
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced that it has submitted its application to the U.S.
Almirall S.A., a global biopharmaceutical company dedicated to medical dermatology, announced today that the National Institute for Health and Care Excellence (NICE) has recommended Ebglyss
A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis.
As many as half of all patients admitted to hospital and other healthcare facilities are malnourished. This has serious consequences for the individual in terms
The study by researchers from the French national public health institute aimed to identify priority pathogens that could be suitable for wastewater surveillance (WWS) during
Using technology to deliver therapy for children and young people is as effective as traditional face-to-face therapy, according to new research.